CHARLES SCHWAB INVESTMENT MANAGEMENT INC - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 279 filers reported holding CONMED CORP in Q1 2022. The put-call ratio across all filers is 3.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$30,772,966
-23.4%
305,136
+3.3%
0.01%
-18.2%
Q2 2023$40,151,690
+33.9%
295,472
+2.3%
0.01%
+22.2%
Q1 2023$29,993,522
+21.4%
288,788
+3.6%
0.01%
+12.5%
Q4 2022$24,712,300
+16.1%
278,794
+5.0%
0.01%0.0%
Q3 2022$21,292,000
-14.5%
265,579
+2.1%
0.01%
-11.1%
Q2 2022$24,906,000
-35.2%
260,078
+0.5%
0.01%
-25.0%
Q1 2022$38,436,000
+6.6%
258,734
+1.7%
0.01%
+9.1%
Q4 2021$36,071,000
+10.5%
254,443
+2.0%
0.01%0.0%
Q3 2021$32,645,000
-2.8%
249,520
+2.2%
0.01%0.0%
Q2 2021$33,570,000
+4.1%
244,266
-1.1%
0.01%
-8.3%
Q1 2021$32,257,000
+12.6%
247,005
-3.4%
0.01%
+9.1%
Q4 2020$28,649,000
+21.3%
255,788
-14.8%
0.01%0.0%
Q3 2020$23,609,000
+8.7%
300,099
-0.6%
0.01%0.0%
Q2 2020$21,726,000
+42.4%
301,785
+13.3%
0.01%
+22.2%
Q1 2020$15,255,000
-39.2%
266,363
+18.6%
0.01%
-30.8%
Q4 2019$25,106,000
+17.5%
224,498
+1.0%
0.01%0.0%
Q3 2019$21,365,000
+18.6%
222,204
+5.5%
0.01%
+18.2%
Q2 2019$18,021,000
-3.0%
210,598
-5.7%
0.01%
-8.3%
Q1 2019$18,576,000
+36.8%
223,317
+5.6%
0.01%
+20.0%
Q4 2018$13,582,000
-12.0%
211,557
+8.6%
0.01%0.0%
Q3 2018$15,438,000
+10.3%
194,873
+1.9%
0.01%0.0%
Q2 2018$13,993,000
+19.5%
191,156
+3.4%
0.01%
+11.1%
Q1 2018$11,707,000
+24.8%
184,850
+0.5%
0.01%
+28.6%
Q4 2017$9,379,000
+2.1%
183,996
+5.2%
0.01%
-12.5%
Q3 2017$9,182,000
+7.7%
174,980
+4.6%
0.01%0.0%
Q2 2017$8,525,000
+17.6%
167,338
+2.5%
0.01%
+14.3%
Q1 2017$7,248,000
+10.5%
163,186
+9.9%
0.01%0.0%
Q4 2016$6,558,000
+21.1%
148,466
+9.8%
0.01%
+16.7%
Q3 2016$5,417,000
-12.0%
135,214
+4.9%
0.01%
-25.0%
Q2 2016$6,156,000
+21.2%
128,959
+6.5%
0.01%
+14.3%
Q1 2016$5,078,000
-1.4%
121,061
+3.6%
0.01%0.0%
Q4 2015$5,148,000
-1.2%
116,855
+7.1%
0.01%
-12.5%
Q3 2015$5,210,000
-18.3%
109,129
-0.3%
0.01%
-11.1%
Q2 2015$6,379,000
-19.6%
109,458
-30.4%
0.01%
-18.2%
Q1 2015$7,937,000
-18.4%
157,182
-27.4%
0.01%
-26.7%
Q4 2014$9,732,000
+15.2%
216,448
-5.6%
0.02%
+7.1%
Q3 2014$8,445,000
-16.8%
229,215
-0.3%
0.01%
-17.6%
Q2 2014$10,155,000
-9.9%
229,993
-11.3%
0.02%
-15.0%
Q1 2014$11,270,000
+5.1%
259,367
+2.8%
0.02%0.0%
Q4 2013$10,725,000
+20.6%
252,348
-2.7%
0.02%
+11.1%
Q3 2013$8,895,000
+4.6%
259,315
-3.2%
0.02%
-5.3%
Q2 2013$8,507,000267,8430.02%
Other shareholders
CONMED CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Iron Triangle Partners LP 217,204$29,850,0003.08%
Ranger Investment Management 260,524$35,804,0001.87%
EARNEST PARTNERS LLC 1,628,848$223,853,0001.32%
Penn Capital Management Company, LLC 87,232$11,988,0001.16%
DeepCurrents Investment Group LLC 257,334$35,365,0001.06%
Champlain Investment Partners, LLC 1,475,989$202,845,0000.96%
Hood River Capital Management LLC 224,050$30,791,0000.92%
OAK RIDGE INVESTMENTS LLC 74,178$10,194,0000.89%
MOODY ALDRICH PARTNERS LLC 45,667$6,276,0000.88%
WAFRA INC. 138,542$19,040,0000.72%
View complete list of CONMED CORP shareholders